Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 24 | 23 | −1 |
| Shares | 1.34M | 3.17M | +1.83M (+137.2%) |
| Value | $3.61M | $6.38M | +$2.77M (+76.8%) |
New holders (4)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,817,454 | $3.65M | 0.10% |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 35,000 | $70.0K | 0.00% |
| Renaissance Technologies LLC | 19,958 | $40.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,289 | $11.0K | 0.00% |
Sold out (5)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Millennium Management LLC | 20,746 | $56.0K |
| Goldman Sachs Group Inc | 19,526 | $53.0K |
| Rede Wealth, LLC | 15,200 | $41.0K |
| Charles Schwab Investment Management Inc | 11,609 | $32.0K |
| Cornerstone Advisory, LLC | 25 | $0 |